Cytogen
Seoul · Founded 2010
About Cytogen
Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment systems for cancer diagnosis and treatment in South Korea. It offers Smart Biopsy, an automated CTC enrichment system from blood sample; and cell isolators, IF stainers, cell image analyzers, time laps analyzers, isolation kits, and culture kits. The company was founded in 2010 and is headquartered in Seoul, South Korea.
Company Facts
- Founded: 2010
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Last round: Series Unknown (Jan 2014)
- Website: cytogenlab.com
- Phone: 82 2 6925 1070
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cytogen-2880207 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.